Today we announced that we've recently closed our $1.2mm seed round, including contributions from Y Combinator, Start Fund, SV Angel, Yuri Milner, Menlo Ventures Talent Fund, Paul Buchheit, Garry Tan, Quotidian Ventures and Crosslink Capital, as well as a range of other angel investors with clinical research and enterprise sales expertise.

"The application of business informatics and analytics is relatively new to clinical research, and the visualization and reporting tools available today are either cumbersome and costly to implement or not tailored to meet the needs of this industry, which comes with complex regulatory requirements,” said Rich Enz, investor and advisor. “Backed by decades of experience in clinical research, Comprehend is working to fill a critical market need for customized tools that easily work with existing systems and enable sponsors to be more effective and strategic with their clinical data."

You can read the full press release here.